949-P: Pharmacist Interventions within a Collaborative Enhanced Primary Care Team Process Improves Diabetes Care
Purpose: An enhanced primary care diabetes model (EPCD) was implemented to provide proactive longitudinal care to adult patients with diabetes, grounded in close partnership between primary care providers (PCP) , registered nurses (RN) , and Medication Management Services (MMS) pharmacists. In this...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2022-06, Vol.71 (Supplement_1) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | Supplement_1 |
container_start_page | |
container_title | Diabetes (New York, N.Y.) |
container_volume | 71 |
creator | HESS, DANIELLE MCCOY, ROZALINA G. MATULIS, JOHN KESSLER, MAYA MARA, KRISTIN HERGES, JOSEPH |
description | Purpose: An enhanced primary care diabetes model (EPCD) was implemented to provide proactive longitudinal care to adult patients with diabetes, grounded in close partnership between primary care providers (PCP) , registered nurses (RN) , and Medication Management Services (MMS) pharmacists. In this model, care team RNs could request pharmacist support through chart review for comprehensive diabetes management. The purpose of this study is to evaluate the impact of the MMS pharmacist in the EPCD model for patients with diabetes.
Methods: All adults with diabetes paneled to a PCP in six primary care clinics in the Midwest U.S. were eligible for the EPCD model. We compared the change in diabetes care quality between patients who received pharmacist chart review and care recommendations to matched patients who did not. The index date was defined as the date of MMS pharmacist review after referral from the care team RN or date of RN review and no subsequent pharmacist consult. The primary outcome was the change in the proportion of patients meeting the composite of four diabetes treatment goals (D4) , including hemoglobin A1c control (HbA1c less than 8%) , blood pressure control (less than 140/90 mmHg) , aspirin use if indicated, and statin use if indicated at six months from the index date. Secondary outcomes were each of the four indicators individually.
Results: The proportion of patients meeting the D4 after 6 months increased with pharmacist chart reviews (N=85) compared to matched patients with no review (N=170) (27% vs. 7%, p |
doi_str_mv | 10.2337/db22-949-P |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2685594907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2685594907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c637-f208726095791a646ccdf69f3b88eaebe1b4428f3eb6355a8f234ffba80aa6593</originalsourceid><addsrcrecordid>eNotkEFLAzEQhYMoWKsXf0HAm7CaTXaTjTdZqxYK7qEHb2GyndAt3d2apBX_vamVOcwwfMy89wi5zdkDF0I9riznmS501pyRSa6FzgRXn-dkwljOs1xpdUmuQtgwxmSqCdn9wU-0WYPvoe1CpPMhoj_gELtxCPS7i-tuoEDrcbsFO3qI3QHpbFjD0OKKNr7rwf_QGjzSJUKfNmOLIdB5v_PjAQN96cBiTMORuSYXDrYBb_77lCxfZ8v6PVt8vM3r50XWSqEyx1mluGS6VDoHWci2XTmpnbBVhYAWc1sUvHICrRRlCZXjonDOQsUAZKnFlNydziYNX3sM0WzGvR_SR8NlVZbJNlOJuj9RrR9D8OjM7mTH5MwcAzXHQE2CTSN-ASIEaOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685594907</pqid></control><display><type>article</type><title>949-P: Pharmacist Interventions within a Collaborative Enhanced Primary Care Team Process Improves Diabetes Care</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>HESS, DANIELLE ; MCCOY, ROZALINA G. ; MATULIS, JOHN ; KESSLER, MAYA ; MARA, KRISTIN ; HERGES, JOSEPH</creator><creatorcontrib>HESS, DANIELLE ; MCCOY, ROZALINA G. ; MATULIS, JOHN ; KESSLER, MAYA ; MARA, KRISTIN ; HERGES, JOSEPH</creatorcontrib><description>Purpose: An enhanced primary care diabetes model (EPCD) was implemented to provide proactive longitudinal care to adult patients with diabetes, grounded in close partnership between primary care providers (PCP) , registered nurses (RN) , and Medication Management Services (MMS) pharmacists. In this model, care team RNs could request pharmacist support through chart review for comprehensive diabetes management. The purpose of this study is to evaluate the impact of the MMS pharmacist in the EPCD model for patients with diabetes.
Methods: All adults with diabetes paneled to a PCP in six primary care clinics in the Midwest U.S. were eligible for the EPCD model. We compared the change in diabetes care quality between patients who received pharmacist chart review and care recommendations to matched patients who did not. The index date was defined as the date of MMS pharmacist review after referral from the care team RN or date of RN review and no subsequent pharmacist consult. The primary outcome was the change in the proportion of patients meeting the composite of four diabetes treatment goals (D4) , including hemoglobin A1c control (HbA1c less than 8%) , blood pressure control (less than 140/90 mmHg) , aspirin use if indicated, and statin use if indicated at six months from the index date. Secondary outcomes were each of the four indicators individually.
Results: The proportion of patients meeting the D4 after 6 months increased with pharmacist chart reviews (N=85) compared to matched patients with no review (N=170) (27% vs. 7%, p<0.001) . The change in patients meeting treatment goals of HbA1c (12.9% vs. 4.1%, p=0.020) , blood pressure (9.4% vs. 2.4%, p=0.023) , aspirin use (10.6% vs. 2.9%, p=0.018) , and statin use (17.6% vs. -1.2%, p<0.001) were increased with a pharmacist review.
Conclusions: Pharmacist engagement in the EPCD model improved diabetes care quality. This supports the inclusion and utilization of pharmacists in multidisciplinary efforts to improve diabetes care.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db22-949-P</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Aspirin ; Blood pressure ; Diabetes ; Diabetes mellitus ; Hemoglobin ; Patients ; Pharmacists ; Primary care</subject><ispartof>Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)</ispartof><rights>Copyright American Diabetes Association Jun 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>HESS, DANIELLE</creatorcontrib><creatorcontrib>MCCOY, ROZALINA G.</creatorcontrib><creatorcontrib>MATULIS, JOHN</creatorcontrib><creatorcontrib>KESSLER, MAYA</creatorcontrib><creatorcontrib>MARA, KRISTIN</creatorcontrib><creatorcontrib>HERGES, JOSEPH</creatorcontrib><title>949-P: Pharmacist Interventions within a Collaborative Enhanced Primary Care Team Process Improves Diabetes Care</title><title>Diabetes (New York, N.Y.)</title><description>Purpose: An enhanced primary care diabetes model (EPCD) was implemented to provide proactive longitudinal care to adult patients with diabetes, grounded in close partnership between primary care providers (PCP) , registered nurses (RN) , and Medication Management Services (MMS) pharmacists. In this model, care team RNs could request pharmacist support through chart review for comprehensive diabetes management. The purpose of this study is to evaluate the impact of the MMS pharmacist in the EPCD model for patients with diabetes.
Methods: All adults with diabetes paneled to a PCP in six primary care clinics in the Midwest U.S. were eligible for the EPCD model. We compared the change in diabetes care quality between patients who received pharmacist chart review and care recommendations to matched patients who did not. The index date was defined as the date of MMS pharmacist review after referral from the care team RN or date of RN review and no subsequent pharmacist consult. The primary outcome was the change in the proportion of patients meeting the composite of four diabetes treatment goals (D4) , including hemoglobin A1c control (HbA1c less than 8%) , blood pressure control (less than 140/90 mmHg) , aspirin use if indicated, and statin use if indicated at six months from the index date. Secondary outcomes were each of the four indicators individually.
Results: The proportion of patients meeting the D4 after 6 months increased with pharmacist chart reviews (N=85) compared to matched patients with no review (N=170) (27% vs. 7%, p<0.001) . The change in patients meeting treatment goals of HbA1c (12.9% vs. 4.1%, p=0.020) , blood pressure (9.4% vs. 2.4%, p=0.023) , aspirin use (10.6% vs. 2.9%, p=0.018) , and statin use (17.6% vs. -1.2%, p<0.001) were increased with a pharmacist review.
Conclusions: Pharmacist engagement in the EPCD model improved diabetes care quality. This supports the inclusion and utilization of pharmacists in multidisciplinary efforts to improve diabetes care.</description><subject>Aspirin</subject><subject>Blood pressure</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Hemoglobin</subject><subject>Patients</subject><subject>Pharmacists</subject><subject>Primary care</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotkEFLAzEQhYMoWKsXf0HAm7CaTXaTjTdZqxYK7qEHb2GyndAt3d2apBX_vamVOcwwfMy89wi5zdkDF0I9riznmS501pyRSa6FzgRXn-dkwljOs1xpdUmuQtgwxmSqCdn9wU-0WYPvoe1CpPMhoj_gELtxCPS7i-tuoEDrcbsFO3qI3QHpbFjD0OKKNr7rwf_QGjzSJUKfNmOLIdB5v_PjAQN96cBiTMORuSYXDrYBb_77lCxfZ8v6PVt8vM3r50XWSqEyx1mluGS6VDoHWci2XTmpnbBVhYAWc1sUvHICrRRlCZXjonDOQsUAZKnFlNydziYNX3sM0WzGvR_SR8NlVZbJNlOJuj9RrR9D8OjM7mTH5MwcAzXHQE2CTSN-ASIEaOQ</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>HESS, DANIELLE</creator><creator>MCCOY, ROZALINA G.</creator><creator>MATULIS, JOHN</creator><creator>KESSLER, MAYA</creator><creator>MARA, KRISTIN</creator><creator>HERGES, JOSEPH</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20220601</creationdate><title>949-P: Pharmacist Interventions within a Collaborative Enhanced Primary Care Team Process Improves Diabetes Care</title><author>HESS, DANIELLE ; MCCOY, ROZALINA G. ; MATULIS, JOHN ; KESSLER, MAYA ; MARA, KRISTIN ; HERGES, JOSEPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c637-f208726095791a646ccdf69f3b88eaebe1b4428f3eb6355a8f234ffba80aa6593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aspirin</topic><topic>Blood pressure</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Hemoglobin</topic><topic>Patients</topic><topic>Pharmacists</topic><topic>Primary care</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HESS, DANIELLE</creatorcontrib><creatorcontrib>MCCOY, ROZALINA G.</creatorcontrib><creatorcontrib>MATULIS, JOHN</creatorcontrib><creatorcontrib>KESSLER, MAYA</creatorcontrib><creatorcontrib>MARA, KRISTIN</creatorcontrib><creatorcontrib>HERGES, JOSEPH</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HESS, DANIELLE</au><au>MCCOY, ROZALINA G.</au><au>MATULIS, JOHN</au><au>KESSLER, MAYA</au><au>MARA, KRISTIN</au><au>HERGES, JOSEPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>949-P: Pharmacist Interventions within a Collaborative Enhanced Primary Care Team Process Improves Diabetes Care</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2022-06-01</date><risdate>2022</risdate><volume>71</volume><issue>Supplement_1</issue><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Purpose: An enhanced primary care diabetes model (EPCD) was implemented to provide proactive longitudinal care to adult patients with diabetes, grounded in close partnership between primary care providers (PCP) , registered nurses (RN) , and Medication Management Services (MMS) pharmacists. In this model, care team RNs could request pharmacist support through chart review for comprehensive diabetes management. The purpose of this study is to evaluate the impact of the MMS pharmacist in the EPCD model for patients with diabetes.
Methods: All adults with diabetes paneled to a PCP in six primary care clinics in the Midwest U.S. were eligible for the EPCD model. We compared the change in diabetes care quality between patients who received pharmacist chart review and care recommendations to matched patients who did not. The index date was defined as the date of MMS pharmacist review after referral from the care team RN or date of RN review and no subsequent pharmacist consult. The primary outcome was the change in the proportion of patients meeting the composite of four diabetes treatment goals (D4) , including hemoglobin A1c control (HbA1c less than 8%) , blood pressure control (less than 140/90 mmHg) , aspirin use if indicated, and statin use if indicated at six months from the index date. Secondary outcomes were each of the four indicators individually.
Results: The proportion of patients meeting the D4 after 6 months increased with pharmacist chart reviews (N=85) compared to matched patients with no review (N=170) (27% vs. 7%, p<0.001) . The change in patients meeting treatment goals of HbA1c (12.9% vs. 4.1%, p=0.020) , blood pressure (9.4% vs. 2.4%, p=0.023) , aspirin use (10.6% vs. 2.9%, p=0.018) , and statin use (17.6% vs. -1.2%, p<0.001) were increased with a pharmacist review.
Conclusions: Pharmacist engagement in the EPCD model improved diabetes care quality. This supports the inclusion and utilization of pharmacists in multidisciplinary efforts to improve diabetes care.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db22-949-P</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-1797 |
ispartof | Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1) |
issn | 0012-1797 1939-327X |
language | eng |
recordid | cdi_proquest_journals_2685594907 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Aspirin Blood pressure Diabetes Diabetes mellitus Hemoglobin Patients Pharmacists Primary care |
title | 949-P: Pharmacist Interventions within a Collaborative Enhanced Primary Care Team Process Improves Diabetes Care |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T07%3A05%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=949-P:%20Pharmacist%20Interventions%20within%20a%20Collaborative%20Enhanced%20Primary%20Care%20Team%20Process%20Improves%20Diabetes%20Care&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=HESS,%20DANIELLE&rft.date=2022-06-01&rft.volume=71&rft.issue=Supplement_1&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db22-949-P&rft_dat=%3Cproquest_cross%3E2685594907%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2685594907&rft_id=info:pmid/&rfr_iscdi=true |